Mapping post-traumatic stress disorder symptoms and quality of life among residents of Wuhan, China after the COVID-19 outbreak: A network perspectiveResearch article Published on 2022-12-012022-10-05 Journal: Journal of affective disorders [Category] 진단, [키워드] approach Attention changes in checklist Chinese Civilian Community conducted connection covariates COVID-19 COVID-19 outbreak cross-sectional cross-sectional survey emotional examined Follow-up General population initial lack life limitation mapping mental health network analysis objective outbreak pandemic participant Perspective Post-traumatic stress disorder Post-traumatic stress disorder symptoms Quality Quality of life Result self-report measure Study design Symptom Version were measured World Health Organization Wuhan Wuhan residents Wuhan, China [DOI] 10.1016/j.jad.2022.08.074 [Article Type] Research article
Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare DiseasesArticle Published on 2022-11-012022-11-16 Journal: Therapeutic innovation & regulatory science [Category] 신약개발, [키워드] advance affected approach children clinical trials COVID-19 COVID-19 pandemic development disease drug ecosystem Efficacy effort engage equity facilitate Follow-up include initiative key factor lack outcome measure Patient pediatric pediatric drug development promote Public public health rare disease rare diseases Regulatory Regulatory policy. Study design Therapies Trial trials [DOI] 10.1007/s43441-022-00409-w PMC 바로가기
Bamlanivimab Use in a Military Treatment FacilityArticle Published on 2022-10-292022-11-15 Journal: Military Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome Administered administration Admission analyzed approval approved Arm bamlanivimab Care caused cohort study coronavirus coronavirus disease COVID-19 COVID-19 patient death declined diagnosed Disease progression facility FDA Follow-up Guidance help hospital Hospital admission Hospitalization information initial inpatient admission institutional review board intravenous IRB lack Mild-to-moderate monoclonal antibody Patient patients patients with SARS-CoV-2 placebo group Prevent Primary outcome progression provided receiving replicated reported required retrospective risk risk factor SARS-CoV-2 secondary outcome self-reported symptom severe COVID-19 small sample size Spread statistical significance statistically significant Study design Symptom treated Treatment treatment group virus-neutralizing was obtained were given Wuhan, China [DOI] 10.1093/milmed/usab188 PMC 바로가기
A Community-Based Participatory Research Approach to Developing and Testing Social and Behavioural Interventions to Reduce the Spread of SARS-CoV-2: A Protocol for the ‘ COPAR for COVID’ Programme of Research with Five Interconnected Studies in the Hong Kong ContextArticle Published on 2022-10-172022-11-15 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 치료기술, [키워드] approach assist behavioural Behavioural intervention children chronic illnesses Community Community intervention community-based participatory research complex Context coronavirus COVID COVID-19 COVID-19 vaccine decrease Decreased develop Developing early testing effort elicit ENhance Ethnic groups example expected Face masks feasibility FIVE groups Health health literacy help high-risk activity Hong Kong hygiene IMPROVE improvement include infection rate Intervention literacy measure new strain Older outcome outcomes Population populations preventative measure prevention preventive measure promote protocol Research scale social distancing social intervention Spread Study design Testing vaccination Vaccine Vaccine hesitancy vaccine hesitancy. variety virus while [DOI] 10.3390/ijerph192013392 PMC 바로가기
Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SPArticle Published on 2022-10-132022-11-16 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] “real world” study. Analysis Brazil calculated ChAdOx1 clinical trial comparable Control Coverage COVID-19 COVID-19 disease COVID-19 pandemic death Delta delta variant demographics dose Effectiveness Efficacy eligible first dose Gamma Hospitalization individual initiated Lineage material municipality offered PCR test PCR tests positive raise reduced reported sequenced severe disease severity state Strains Study design symptomatic infection Symptoms unique vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose Vaccines variant variants of concern variants of SARS-CoV-2 [DOI] 10.3389/fpubh.2022.1016402 PMC 바로가기
Optimizing the implementation of a participant-collected, mail-based SARS-CoV-2 serological survey in university-affiliated populations: lessons learned and practical guidanceArticle Published on 2022-10-122022-11-15 Journal: BMC Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] antibody applicability approach Blood change distribution driven by enrolled Epidemiologic methods feasibility Field epidemiology Future Guidance highlight identify implementation Laboratory Massachusetts Pathogens pre-symptomatic Prevalence recruitment Research SARS-CoV-2 SARS-CoV-2 antibody serological survey serological test serology Serosurveys. Spread stratified Study design Study participants subclinical infection symptomatic individual USA utility virus [DOI] 10.1186/s12889-022-14234-1 PMC 바로가기
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachArticle Published on 2022-10-012022-11-15 Journal: EBioMedicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Analysis applied approach calibrated candidate carried clinical Clinical efficacy clinical trial convalescent CoronaVac COVID-19 COVID-19 pandemic COVID-19 vaccine develop Efficacy humans immunogenicity data Inc. joint literature review LLC Meta-analysis Model-based meta-analysis (MBMA) modelling Modelling and simulation Neutralizing predict predicted Predictive Predictive model Quantitative reported rhesus macaque Safe SARS-CoV-2 SARS-CoV-2 vaccines serum Sharp strain Study design Support systematic literature search the mean titre translation translational USA vaccination Vaccine vaccine candidate Vaccines. variant Viral load were used [DOI] 10.1016/j.ebiom.2022.104264 PMC 바로가기
Maternal mental health and breastfeeding amidst the Covid-19 pandemic: cross-sectional study in Catalonia (Spain)Article Published on 2022-09-262022-11-16 Journal: BMC Pregnancy and Childbirth [Category] SARS, 치료기술, [키워드] abnormality adverse outcome Affect age Anxiety bonding Breastfeeding carried conducted COVID-19 cross-sectional cut-off Depressive symptoms detect Edinburgh emotional enrolled First wave Follow-up health emergency hospital increase in infectious risk lactating lockdown Maternal Maternal mental health. mental health mother Neonatal Newborn outcome pandemic Postpartum pregnant women prospective observational study scale significant increase Spain step Study design women [DOI] 10.1186/s12884-022-05036-9 PMC 바로가기
Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratoriesArticle Published on 2022-09-242022-11-16 Journal: BMC Public Health [Category] SARS, 유전자 메커니즘, [키워드] bioinformatics Canada Capacity capacity building Contact tracing COVID-19 diagnostic Diseases early stage effective genomic Genomics Health Laboratory pandemic pathogen Public public health Public health laboratory public health measures Research resource SARS-CoV-2 SARS-CoV-2 genome sequencing SARS-CoV-2 genomic surveillance specimen Study design Surveillance surveillance. unique Variability [DOI] 10.1186/s12889-022-14210-9 PMC 바로가기
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego CountyArticle Published on 2022-09-052022-10-05 Journal: Addiction Science & Clinical Practice [Category] SARS, 임상, [키워드] analyses Antigen board cohort study Community condition COVID-19 COVID-19 testing COVID-19 vaccination develop Diego drug effect size Efficacy estimate event facilitate finding Follow-up harm reduction health authorities Health status impacted include information intake Intervention intravenous lesson Local Motivational interviewing offer organization outcomes participant pilot study Population populations Precision protocol Randomized Randomized controlled trial RCT recruit reduction Registered SARS-CoV-2 severe disease state health department Study design substance Substance use Support Trial vaccination vulnerable populations. [DOI] 10.1186/s13722-022-00328-z PMC 바로가기 [Article Type] Article